9th Feb 2006 11:00
Smith & Nephew Plc09 February 2006 Smith & Nephew senior management appointments 9 February 2006 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business,announced today that it has made three new Business Unit President appointmentswith immediate effect. Smith & Nephew's Orthopaedics business has grown strongly in the last fiveyears, with performance consistently ahead of its markets. To develop thisbusiness further, we are now identifying two separate business units;Orthopaedic Reconstruction and Orthopaedic Trauma (including ClinicalTherapies). This change is at the heart of our strategy to focus our businesseson the markets and customers that they serve. Scott Flora, currently Senior Vice-President and General Manager of theReconstructive Division, is promoted to President Orthopaedic Reconstruction.Scott has over 20 years experience in the medical device industry includingworking with companies such as Johnson & Johnson. He joined Smith & Nephew in1986 as a sales representative and was progressively promoted becoming SeniorVice-President of Trauma and Clinical Therapies Division in 2003. In March 2005he was appointed to his current role. Mark Augusti is promoted to President Orthopaedic Trauma and Clinical Therapies.Mark started his career in sales with GE Medical Systems and spent 13 yearsthere in a number of roles based in the US and Asia. He joined Smith & Nephewin April 2003 as Vice President of Global Marketing for the Trauma Division andwas promoted to Senior Vice-President and General Manager Trauma Division inMarch 2005. After 30 years with Smith & Nephew, the last seven years as President ofAdvanced Wound Management, Jim Dick will be retiring in the summer of this year. Joe Woody, currently the Vice President and General Manager of the ClinicalTherapies Division, has been appointed as Jim's successor as President ofAdvanced Wound Management. Joe has 20 years experience in marketing and salesand worked for Alliance Imaging, Acuson and GE Medical Systems before joiningSmith & Nephew in 2003. Under his leadership Clinical Therapies has grownrapidly into a significant business. Joe will re-locate to the UK to take uphis new role. Sir Christopher O'Donnell, Chief Executive of Smith & Nephew, commenting onthese appointments today said: "Smith & Nephew's Orthopaedics business has grown substantially in recent yearswith performance consistently ahead of its markets. As a consequence ofsegmenting our Orthopaedics business we are able to promote two highly talentedpeople to President. The appointment of Scott Flora and Mark Augusti coincidewith an exciting time for these businesses with excellent opportunities forcontinued above market growth." "Joe Woody has made a major contribution in leading the excellent growthachieved by Clinical Therapies. We look forward to benefiting from his broadexperience in sales and marketing, particularly in the United States, inaccelerating growth in our Advanced Wound Management business." Commenting on Jim Dick's retirement, Christopher O'Donnell added: "Under JimAdvanced Wound Management has evolved into a global leader with strong marketpositions in all major countries of the world. I would like to thank Jim forhis contribution to the Group over many years." Enquiries InvestorsSir Christopher O'Donnell Tel: +44 (0) 20 7401 7646Smith & NephewChief Executive Investors / MediaLiz Hewitt Tel: +44 (0) 20 7401 7646Smith & NephewGroup Director Corporate Affairs About us Smith & Nephew is a global medical technology business, specialising inOrthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephewis a global leader in arthroscopy and advanced wound management and is one ofthe fastest growing global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The company has over 8,500employees and operates in 33 countries around the world generating annual salesof $2.6 billion. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew